Molecular mechanisms responsible for the involvement of tissue transglutaminase in human diseases: Celiac disease

Frontiers in Bioscience

Volumn 11, Issue 1 P.1-446, 2006, Pages 249-255

  Amantea, Giuseppe ^a   Cammarano, Marisa ^a   Zefferino, Lucia ^a   Martin, Antonio ^a   Romito, Gennaro ^a   Piccirillo, Mariapina ^a   Gentile, Vittorio ^a,b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b NONE   (Italy)

Author keywords

Celiac Disease; Polyglutamine proteins; Post Translational Modifications; Review; Tissue Transglutaminase

Indexed keywords

EID: 32844470135     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1795     Document Type: Review

References (17)

1. Trier J.S. Celiac sprue. N. Eng. J. Med. 325, 1709-1719 (1991)
2. Roizen N.J., D. Patterson: Down's syndrome. The Lancet. 361, 1281-1289 (2003)
3. Corazza G.B., Biagi F., Andreani M. L. and G. Gasbarrini: Clinical and biological characteristics of gluten intolerance. In: Epilepsy and Other Neurological Disorders in Coeliac Disease; by G. Gobbi, F. Andermann, S. Naccarato and G. Bianchini Eds. 7-11 (1997)
4. Molberg O., McAdam S. N. and L. Sollid: M. Role of tissue transglutaminase in Coeliac Disease. Journal of Pediatric Gastroenterology and Nutrition. 30, 232-240 (2000)
5. Sollid L.M., E. Thorsby: HLA susceptibility genes in Celiac disease: Genetic mapping and role in pathogenesis. Gastroenterology. 105, 910-922 (1993)
6. Arentz-Hansen H., Korner R., Molberg O., Quarsten H., Vader W., Kooy Y.M.C., Lundin K.E.A., Koning F., Roepstorff P., Sollid L. and S.N. McAdam: The intestinal T cell response to α-gliadin in adult Celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J. Exp. Med. 191, 603-612 (2000)
7. Kim C.Y., Quarsten H., Bergseng E., Khosla C., L.M. Sollid: Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci USA. 101, 4175-9 (2004)
8. Anderson R.P., Degano P., Godkin A.J., Jewell D.P., and A. Hill: V. S. In vivo antigen challenge in Celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nature Medicine. 6, 337-342 (2000)
9. Dietrich W., Ehnis T., Bauer M., Donner P., Volta U., Riecken E. O. and D. Schuppan: Identification of tissue transglutaminase as the autoantigen of Coeliac disease. Nature Medicine. 3, 797-801 (1997)
10. Bruce S.E., Bjarnason I., T.J. Peters: Human jejunal transglutaminase: Demonstration of activity, enzyme kinetics and substrate specificity with special relation to gliadin and Coeliac disease. Clin. Sci. (Colch) 68, 573-579 (1985;
11. Fleckenstein B., Qiao S.W., Larsen M.R., Jung G., Roepstorff P., L.M. Sollid: Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides. J. Biol. Chem. 279, 17607-16 (2004)
12. Porta R., Gentile V., Esposito C., Mariniello L., and S. Auricchio: Cereal dietary proteins with sites for cross-linking by transglutaminase. Phytochemistty. 29, 2801-2804 (1990)
13. Gentile V., Sepe C., Calvani M., Melone M. A. B., Cotrufo R., Cooper A. J. L., Blass J. P., G. Peluso: Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains: A possible mechanism contributing to CAG-triplet diseases. Arch. Biochem. Biophys. 352, 314-321 (1998)
14. Igarashi S., Koide R., Shimohata T., Yamada M., Hayashi Y., Takano H., Date H., Oyake M., Sato A., Egawa S., Ikeuchi T., Tanaka H., Nakanao R., Tanaka K., Hozumi I., Inuzuka T., Takahashi H., S. Tsuji: Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat. Genet. 18, 111-117 (1998)
15. Green, H.: Human genetic diseases due to codon reiteration: Relationship to an evolutionary mechanism. Cell. 74, 955-956 (1993)
16. Auricchio S., De Ritis G., De Vincenzi M., Gentile V., Maiuri L., Mancini E., Porta R. and V. Raia: Amines protect in vitro the celiac small intestine from the damaging activity of gliadin peptides. Gastroenterology. 99, 1668-1674 (1990)
17. Schmidt G., Selzer J., Lerm M., K. Aktories: The rho-deamidating cytotoxic necrotizing factor 1 from escherichia coli possesses transglutaminase activity: Cysteine 866 and histidine 881 are essential for enzyme activity. J. Biol. Chem. 273, 13669-74 (1998)